Repeated photodynamic therapy using a chlorin e6‐embedded device to prolong the therapeutic effects on obesity
Obesity · 2024
DOI: 10.1002/oby.23958 ↗At a glance
Journal article in Obesity, 2024. Written by Jung-Hoon Park and 9 co-authors. Institution: Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea. Major MEDLINE topics: Photochemotherapy, Porphyrins, Obesity, Photosensitizing Agents. Cited 4 times so far (Crossref); 44 references. Funded by: Korea Medical Device Development Fund, National Research Foundation of Korea (NRF).
Abstract (original language)
Objective
This study aimed to investigate the efficacy and safety of repeated photodynamic therapy (PDT) with a chlorin e6 (Ce6)‐embedded intragastric satiety‐inducing device (ISD) to maintain therapeutic effects of obesity in a juvenile pig.
Methods
The Ce6‐embedded ISD was fabricated with a dipping method. Twelve pigs were divided into four groups of three and were administered control, single, biweekly, or weekly PDT, respectively. The therapeutic effects were assessed by comparing the results of phototoxicity, endoscopy, fluoroscopy, hormone and weight changes, and histological examination.
Results
The percentage of total body weight gain was significantly suppressed in PDT‐treated pigs compared with control pigs (all p < 0.001). This suppression persisted in the repeated PDT groups, but percentage of total body weight gain gradually increased when PDT was stopped. Ghrelin levels in the PDT‐treated groups were significantly lower and leptin levels were significantly higher than those in the control group (all p < 0.05). Inflammatory cell infiltration, collagen, TUNEL, and anti‐ghrelin‐positive deposition in the weekly group were significantly higher than those in the control, single, and biweekly groups (all p < 0.01).
Conclusions
Repeated and periodic PDT was technically feasible and safe and successfully maintained the therapeutic effects against obesity while eliminating the indwelling time and reducing ISD‐related complications in pigs.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
- Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Biotechnology, Department of Biomedical-Chemical Engineering, The Catholic University of Korea, Bucheon-si, Republic of Korea.
ORCID profiles: Jung-Hoon Park, Ji Won Kim, Dae Sung Ryu, Hyeonseung Lee, Jin Hee Noh, Do Hoon Kim, Kun Na, Hwoon-Yong Jung
Funding
- Korea Medical Device Development Fund
- National Research Foundation of Korea (NRF)
Cite
APA
Park, J. H., Kim, J. W., Ryu, D. S., Lee, H., Na, H. K., Noh, J. H., Kim, D. H., Lee, S., Na, K., & Jung, H. Y. (2024). Repeated photodynamic therapy using a chlorin e6‐embedded device to prolong the therapeutic effects on obesity. Obesity. https://doi.org/10.1002/oby.23958
Vancouver
Park JH, Kim JW, Ryu DS, Lee H, Na HK, Noh JH, et al. Repeated photodynamic therapy using a chlorin e6‐embedded device to prolong the therapeutic effects on obesity. Obesity. 2024. doi:10.1002/oby.23958
BibTeX
@article{Park2024,
author = {Park, Jung-Hoon and Kim, Ji Won and Ryu, Dae Sung and Lee, Hyeonseung and Na, Hee Kyong and Noh, Jin Hee and Kim, Do Hoon and Lee, Sanghee and Na, Kun and Jung, Hwoon-Yong},
title = {Repeated photodynamic therapy using a chlorin e6‐embedded device to prolong the therapeutic effects on obesity},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.23958}
}
EUVIMED